Viewing Study NCT02639260

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:16 AM

Ignite Modification Date: 2026-03-06 @ 6:38 PM

Study NCT ID: NCT02639260

Status: COMPLETED

Last Update Posted: 2023-02-24

First Post: 2015-12-23

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module